PD-1 Inhibitors in Recurrent or Metastatic Oral Squamous Cell Carcinoma: Clinical Evidence, Patient Selection, and Immune-Related Toxicities. (2026). Journal of Oral Health and Dental Therapeutics, 1(1), 27-31. https://doi.org/10.68041/johdt.v1i1/06